There are only a few companies that come around every half-decade or so that really get the gears turning in terms of having the right fundamental makeup for value investors. It just so happens that these companies (when caught early on) are too small to even be on the radar of the bigger sharks in the financial markets, which is where average retail investors get the chance to act on an inherent advantage.
[content-module:CompanyOverview|NYSE:HIMS]Today’s opportunity comes within the medical sector, though this company has managed to sprinkle just enough technology and innovation to make it a potential disruptor in the industry. This factor has made it past the thesis stage and into the subtle realities of the company and its future, as seen in the key performance indicators (KPIs) within the latest quarterly earnings report.
